Search Prime Grants

U19AI062629

Cooperative Agreement

Overview

Grant Description
MOLECULAR AND IMMUNOLOGIC ANALYSIS OF THE PATHOBIOLOGY OF ANTHRAX
Awardee
Oklahoma Medical Research Foundation
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
93.855 - Allergy and Infectious Diseases Research
Awarding / Funding Agency
National Institute of Allergy and Infectious Diseases (NIAID) [HHS - NIH]
Place of Performance
Oklahoma City, Oklahoma 731045005 United States
Geographic Scope
Single Zip Code
Related Opportunity
Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) (RFA-AI-17-040)
Analysis Notes
COVID-19 $2,226,033 (5%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the 2020 Coronavirus Preparedness and Response Supplemental Appropriations Act.
Amendment Since initial award the End Date has been extended from 08/31/09 to 08/31/25 and the total obligations have increased 1630% from $2,616,353 to $45,255,857.
Oklahoma Medical Research Foundation was awarded Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax Cooperative Agreement U19AI062629 worth $45,255,857 from the National Institute of Allergy and Infectious Diseases in September 2004 with work to be completed primarily in Oklahoma City Oklahoma United States. The grant has a duration of 21 years and was awarded through assistance program 93.855 Allergy and Infectious Diseases Research. The Cooperative Agreement was awarded through grant opportunity Cooperative Centers on Human Immunology (U19 Clinical Trial Optional).

Status
(Complete)

Last Modified 9/20/24

Period of Performance
9/15/04
Start Date
8/31/25
End Date
100% Complete

Funding Split
$45.3M
Federal Obligation
$0.0
Non-Federal Obligation
$45.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U19AI062629

Subgrant Awards

Disclosed subgrants for U19AI062629

Transaction History

Modifications to U19AI062629

Additional Detail

Award ID FAIN
U19AI062629
SAI Number
U19AI062629-16709169
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NM00 NIH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Funding Office
75NM00 NIH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Awardee UEI
NGCNCJ1X6XA4
Awardee CAGE
4X200
Performance District
OK-05
Senators
James Lankford
Markwayne Mullin

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Health and Human Services (075-0885) Health research and training Grants, subsidies, and contributions (41.0) $25,030,469 100%
Modified: 9/20/24